pentobarbital will minimize the level or effect of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will lower the extent or outcome of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advised; solid cytochrome P450 enzyme inducers minimiz